Omzet 2024 * | 48,96 mld. 45,46 mld. | Omzet 2025 * | 50,79 mld. 47,16 mld. | Marktkapitalisatie | 208 mld. 193 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 10,5 mld. 9,75 mld. | Nettowinst (verlies) 2025 * | 12,07 mld. 11,21 mld. | EV/omzet 2024 * | 4,51 x |
Nettoschuld 2024 * | 12,88 mld. 11,96 mld. | Nettoschuld 2025 * | 11,28 mld. 10,47 mld. | EV/omzet 2025 * | 4,31 x |
K/w-verhouding 2024 * |
20,2
x | K/w-verhouding 2025 * |
17,3
x | Werknemers | 76.057 |
Dividendrendement 2024 * |
3,55% | Dividendrendement 2025 * |
3,68% | Vrij verhandelbaar | 85,22% |
Recentste transcriptie over Novartis AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 01-01-05 | |
Director of Finance/CFO | 59 | 01-01-03 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16-05-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01-01-13 |
Simon Moroney
BRD | Director/Board Member | 65 | 28-02-20 |
Chairman | 68 | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. | |
-2,71% | 159 mld. |